Association between TNF-ɑ-308G/A polymorphism and esophageal cancer risk: An updated meta-analysis and trial sequential analysis

Por Yang, Fengming, Wei, Ke, Qin, Zhiqiang, Shao, Chuchu, Shu, Yongqian, Shen, Hua
Publicado no J Cancer (2019)

The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis

Por Shao, Chuchu, Yang, Fengming, Qin, Zhiqiang, Jing, Xinming, Shu, Yongqian, Shen, Hua
Publicado no BMC Cancer (2019)

Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts

Por Yang, Fengming, Ning, Zhiqiang, Ma, Ling, Liu, Weitao, Shao, Chuchu, Shu, Yongqian, Shen, Hua
Publicado no Mol Cancer (2017)

Association between VEGF Gene Polymorphisms and the Susceptibility to Lung Cancer: An Updated Meta-Analysis

Por Yang, Fengming, Qin, Zhiqiang, Shao, Chuchu, Liu, Weitao, Ma, Ling, Shu, Yongqian, Shen, Hua
Publicado no Biomed Res Int (2018)

Role of hypoxia-induced exosomes in tumor biology

Por Shao, Chuchu, Yang, Fengming, Miao, Suyu, Liu, Weitao, Wang, Chaoshan, Shu, Yongqian, Shen, Hua
Publicado no Mol Cancer (2018)

Role of hypoxia in cancer therapy by regulating the tumor microenvironment

Por Jing, Xinming, Yang, Fengming, Shao, Chuchu, Wei, Ke, Xie, Mengyan, Shen, Hua, Shu, Yongqian
Publicado no Mol Cancer (2019)

4-Hydroxy estrogen metabolite, causing genomic instability by attenuating the function of spindle-assembly checkpoint, can serve as a biomarker for breast cancer

Por Miao, Suyu, Yang, Fengming, Wang, Ying, Shao, Chuchu, Zava, David T, Ding, Qiang, Shi, Yuenian Eric
Publicado no Am J Transl Res (2019)

High discrepancy in thrombotic events in non-small cell lung cancer patients with different genomic alterations

Por Liu, Yiwei, Wang, Wanying, Wu, Fengying, Gao, Guanghui, Xu, Jian, Li, Xuefei, Zhao, Chao, Yang, Shuo, Mao, Shiqi, Pan, Yingying, Jia, Keyi, Shao, Chuchu, Chen, Bin, Ren, Shengxiang, Zhou, Caicun
Publicado no Transl Lung Cancer Res (2021)

Adenocarcinoma of High-Grade Patterns Associated with Distinct Outcome of First-Line Chemotherapy or EGFR-TKIs in Patients of Relapsed Lung Cancer

Por Yu, Xiaofei, Dong, Zhengwei, Wang, Wanying, Mao, Shiqi, Pan, Yingying, Liu, Yiwei, Yang, Shuo, Chen, Bin, Wang, Chunyan, Li, Xuefei, Zhao, Chao, Jia, Keyi, Shao, Chuchu, Wu, Chunyan, Ren, Shengxiang, Zhou, Caicun
Publicado no Cancer Manag Res (2021)